CN104055769A - Novel prescription, delivering device and preparation method for metronidazole, clotrimazole and chlorhexidine acetate compound ointment - Google Patents

Novel prescription, delivering device and preparation method for metronidazole, clotrimazole and chlorhexidine acetate compound ointment Download PDF

Info

Publication number
CN104055769A
CN104055769A CN201310089160.3A CN201310089160A CN104055769A CN 104055769 A CN104055769 A CN 104055769A CN 201310089160 A CN201310089160 A CN 201310089160A CN 104055769 A CN104055769 A CN 104055769A
Authority
CN
China
Prior art keywords
ointment
feeding machine
pencil
medicine feeding
minutes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201310089160.3A
Other languages
Chinese (zh)
Inventor
于静洪
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shanqing Pharmaceutical Co Ltd North Town City
Original Assignee
Shanqing Pharmaceutical Co Ltd North Town City
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanqing Pharmaceutical Co Ltd North Town City filed Critical Shanqing Pharmaceutical Co Ltd North Town City
Priority to CN201310089160.3A priority Critical patent/CN104055769A/en
Publication of CN104055769A publication Critical patent/CN104055769A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention discloses a novel prescription, portable delivering device and preparation method for a metronidazole, clotrimazole and chlorhexidine acetate compound ointment. The invention is characterized in that the compound ointment is prepared from the following components by using specially-produced internal and external packing according to specific flow process: on the basis of weight, 10 to 15% of ornidazole, 3 to 8% of miconazole nitrate, 0.1 to 1% of chlorhexidine acetate and matrix adjuvant (consisting of 0.3 to 5% of sodium carboxymethyl starch, 0.3 to 5% of carboxymethylcellulose sodium, 0.1 to 3% of carbomer, 20 to 30% of glycerin, 0 to 1% of polyethylene glycol, 0 to 1% poloxamer, 0 to 1% of laurocapram, 0 to 1% of triethanolamine and 40 to 70% of purified water). The ointment is prepared from the above-mentioned materials by using a specific process and is then sealed in the portable delivering device. The invention has the following beneficial effects: the ointment has improved drug effects, reduced side-effects and decreased adverse reaction, is uniform, fine and properly viscous, can be easily smeared on the mucous membrane of a focus of the vagina, is convenient to carry when one goes out, eliminates discomforts like pain during vaginal administration, enhances medication comfortableness, promotes drug absorption, improves bioavailability and shortens a treatment period.

Description

The safe compound ointment agent of a kind of new two azoles prescription, medicine feeding machine and preparation method thereof
The invention discloses the safe compound ointment preparation prescription of a kind of new two azoles, portable medicine feeding machine and preparation method thereof.
Vaginitis is the inflammation of connective tissue under vaginal mucosa and mucosa, vaginitis clinically taking the character of leucorrhea change and pruritus vulvae causalgia as main clinical characters, sexual anhedonia is also common, when urethra is involved in infection, can there is the symptom such as dysurea, urgent micturition, bring very large worries to patient's live and work.Common vaginitis has bacterial vaginitis, trichomonal vaginitis, colpitis mycotica, senile vaginitis.
Bacterial vaginitis is that Gardnerella, various anaerobe, bending vibrio etc. are main a kind of mixed infection.Colpitis mycotica is to be caused by fungal infections such as Candida albicans.Trichomonal vaginitis is trichomonal a kind of vaginitis per vaginam.
Middle-aged women is suffered from vaginitis, not only can occur Simple infection vaginitis, and mixed infective vaginitis also can occur, as: the vaginitis of Candida albicans, anaerobe, infusorian property, haemophilus, two or more concurrent infections of corynebacterium.Mixed infective vaginitis state of an illness more complicated, treatment needs comprehensive medication, but the medicine of applying clinically at present, be single prescription, do not reach Comprehensive Treatment object, or be some compound preparations before more than 20 years, drug effect is low, side effect is large, is therefore badly in need of developing a kind of new compound preparation, meets patient's Comprehensive Treatment demand.
Object of the present invention is exactly to prepare that a kind of mastic granularity is little, even, fine and smooth, denseness is suitable, be easy to be coated on the portable new compound preparation on the focus mucosa of vagina, meets patient treatment demand.According to the study, ornidazole is third generation 5-nitro glyoxaline antibiotic, with respect to metronidazole, more obvious to the therapeutic effect of anaerobe and trichomonal vaginitis, and side effect obviously reduces; Miconazole nitrate is that imidazoles antifungal agent has good killing action to vagina Candida albicans, and chlorhexidine acetate is cationic germicide, and has a broad antifungal spectrum has killing action to most Grain-positives and negative bacteria.Therefore the present invention has selected following three kinds of principal agents: ornidazole, miconazole nitrate, chlorhexidine acetate.In order to allow, mastic granularity is little, even, fine and smooth, denseness is suitable, be easy to be coated on the focus mucosa of vagina, and the present invention has taked particular substrate supplementary product kind and ratio, special portable medicine feeding machine, and special preparation technique.
Ointment of the present invention is made up of the component of following weight percentage, ornidazole 10-15%, miconazole nitrate 3-8%, chlorhexidine acetate 0.1-1%, substrate adjuvant (substrate adjuvant is carboxymethyl starch sodium 0.3-5%, sodium carboxymethyl cellulose 0.3-5%, carbomer 0.1-3%, glycerol 20-30%, Polyethylene Glycol 0-1%, poloxamer 0-1%, laurocapram 0-1%, triethanolamine 0-1%, purified water 40-70%).
Ointment of the present invention is to prepare by special process below:
1, by ornidazole 10-15%, miconazole nitrate 3-8%, pulverizes with pulverizer, crosses 80-150 mesh sieve, and fine powder packs in clean plastic bag, after tightening, puts into stainless steel cask, stand-by.
2,, by purified water 40-70%, be heated to 40 DEG C-90 DEG C.By chlorhexidine acetate 0.1-1%, add in above-mentioned purified water, fully stir, it is dissolved completely, become settled solution.
3, by triethanolamine 0-1%, poloxamer 0-1%, Polyethylene Glycol 0-1%, carbomer 0.1-3%, glycerol 0-30%, carboxymethyl starch sodium 0.3-5%, sodium carboxymethyl cellulose 0.3-5%, laurocapram 0-1% sows in 2 solution, it is fully infiltrated with polishing, grind exquisiteness, make it fully swelling.
4, by the ornidazole 10-15% in 1, miconazole nitrate 3-8%, puts in mixer, mixes 30-90 minute, obtains uniform mixed powder.
5, by the mixed powder in 4, slowly join in the thickness paste substrate in 3, stir while adding.Mixing speed is 50-80 rev/min, after all adding, takes batch type.Front stirring respectively for twice 10 minutes, leaves standstill 5 minutes; Stir for the 3rd time after 10 minutes, leave standstill 90 minutes, make it fully swelling; Then stir 30 minutes, leave standstill 10 minutes; Stir again 5 minutes, leave standstill 10 minutes; Continue to be stirred to material in tank and become thick mastic, then after colloid mill grinds, sealing and standing 12-72 hour.
6, medicine feeding machine is carried out to inside and outside wall sterilization, column top is plugged in pencil fixed position, by the mastic in 5, be distributed in medicine feeding machine's pencil, by pipe cap sealing, aluminium-plastic sealing packaging, then with the band handle top bolt mounted box of independent aluminium-plastic sealing, to obtain final product.
Advantage of the present invention is:
By optimizing preparation prescription, prepare the safe ointment of the two azoles of a new generation, increase drug effect, reduced side effect, reduced untoward reaction, mastic granularity is little, evenly, exquisiteness, denseness is suitable, is easy to be coated on the focus mucosa of vagina, goes out to be with medicine portable, remove when vagina administration the uncomfortable sensations such as pain, improve medication comfortableness, improve treatment compliance, shorten treatment cycle.
The mastic granularity of this ointment is little, even, fine and smooth, and denseness is suitable, be easy to be coated on the focus mucosa of vagina, increase drug release solution absorption, and nonirritant, medicine pharmacological action improved, improve the safety of medication, more portable while making patient go out to be with medicine, while having removed patient's vagina administration, the uncomfortable sensation such as pain, has improved medication comfortableness, improve Treatment Compliance, shortened treatment cycle.
Embodiments of the invention:
Component Percentage by weight
Ornidazole 10-15%
Miconazole nitrate 3-8%
Chlorhexidine acetate 0.1-1%
Carboxymethyl starch sodium 0.3-5%
Sodium carboxymethyl cellulose 0.3-5%
Carbomer 0.1-3%
Glycerol 20-30%
Polyethylene Glycol 0-1%
Poloxamer 0-1%
Laurocapram 0-1%
Triethanolamine 0-1%
Purified water 40-70%
Ointment loading amount 4 grams every
[0019]as shown in Figure 1, it has a pencil 2 to said portable medicine feeding machine, in pencil 2, ointment is housed, elastic packing pipe cap 1 is equipped with on pencil 2 tops, and column top plug 4 is equipped with at pencil 2 rear portions, has a groove with the side of handle top bolt 5, and independent packaging, disposable body lotion 6 independent packagings.Before perfusion ointment, by the whole sterilizations of above-mentioned article inside and outside wall, and column top plug 4 is placed in to assigned position, according to loading amount, ointment is poured in pencil 2, then seal pencil 2 front ends with pipe cap 1, aluminum-plastic packaged.Used time is taken out the band handle top bolt 5 of independent packaging, be assembled in pencil 2 rear portions, pipe cap 1 is pulled out, the body lotion of independent packaging 6 is extruded, painting is opened up in pencil 2 outer walls, pencil 2 is sent into gently to the affected area of vagina, push belt handle top bolt 5 takes out medicine feeding machine and abandons it after ointment is all injected.Two drawbacks of current medicine feeding machine are so just solved: (1) is because medicine feeding machine's pipe shaft is long at present, patient is in the time going out, carrying medicine does not put just, medicine feeding machine in the present invention, because band handle top bolt 5 is independent packagings, just medicine feeding machine's entire length is foreshortened to half, facilitated patient to carry.(2) while using current medicine feeding machine's administration, a lot of patients can feel pudendum pain or uncomfortable, the body lotion 6 in the present invention, the discomfort sensation while just having removed patient's medication.
Fig. 1 is portable medicine feeding machine's of the present invention schematic diagram
The 1st, elastic packing pipe cap
The 2nd, pencil
The 3rd, ointment
The 4th, column top plug
The 5th, band handle top bolt
The 6th, disposable body lotion.

Claims (3)

1. the safe compound ointment preparation prescription of new two azoles, portable medicine feeding machine and preparation method thereof, feature of the present invention is, ornidazole 10-15%, miconazole nitrate 3-8%, chlorhexidine acetate 0.1-1%, substrate adjuvant (substrate adjuvant is carboxymethyl starch sodium 0.3-5%, sodium carboxymethyl cellulose 0.3-5%, carbomer 0.1-3%, glycerol 20-30%, Polyethylene Glycol 0-1%, poloxamer 0-1%, laurocapram 0-1%, triethanolamine 0-1%, purified water 40-70%).Above-mentioned material was pulverized to 100 mesh sieves by special process, dosing, preparation ointment, is sealed in the ointment of making in portable medicine feeding machine of the independent packaging through inside and outside wall sterilizing that meets human physiological structure.
2. according to the said compound ointment preparation method of claim 1, it is characterized in that:
2.1 by ornidazole 10-15%, and miconazole nitrate 3-8% pulverizes with pulverizer, crosses 80-150 mesh sieve, and fine powder packs in clean plastic bag, after tightening, puts into stainless steel cask, stand-by.
2.2,, by purified water 40-70%, be heated to 40 DEG C-90 DEG C.By chlorhexidine acetate 0.1-1%, add in above-mentioned purified water, fully stir, it is dissolved completely, become settled solution.
2.3, by triethanolamine 0-1%, poloxamer 0-1%, Polyethylene Glycol 0-1%, carbomer 0.1-3%, glycerol 0-30%, carboxymethyl starch sodium 0.3-5%, sodium carboxymethyl cellulose 0.3-5%, laurocapram 0-1% sows in 2.2 solution, it is fully infiltrated with polishing, grind exquisiteness, make it fully swelling.
2.4, by the ornidazole 10-15% in 2.1, miconazole nitrate 3-8%, puts in mixer, mixes 30-90 minute, obtains uniform mixed powder.
2.5, by the mixed powder in 2.4, slowly join in the thickness paste substrate in 2.3, stir while adding.Mixing speed is 50-80 rev/min, after all adding, takes batch type.Front stirring respectively for twice 10 minutes, leaves standstill 5 minutes; Stir for the 3rd time after 10 minutes, leave standstill 90 minutes, make it fully swelling; Then stir 30 minutes, leave standstill 10 minutes; Stir again 5 minutes, leave standstill 10 minutes; Continue to be stirred to material in tank and become thick mastic, then after colloid mill grinds, sealing and standing 12-72 hour.
2.6, medicine feeding machine is carried out to inside and outside wall sterilization, column top is plugged in pencil fixed position, by the mastic in 2.5, be distributed in medicine feeding machine's pencil, by pipe cap sealing, aluminium-plastic sealing packaging, then with the band handle top bolt mounted box of independent aluminium-plastic sealing, to obtain final product.
3. according to the said compound ointment of claim 1, be sealed in medicine feeding machine, above-mentioned medicine feeding machine's feature is: medicine feeding machine is accompanied with the human body lubricants that meets hygienic requirement, medicine feeding machine is by pencil, pipe cap, column top plug, band handle top bolt forms, it is circular-arc that pencil front end is round and smooth closing in, and there is an insecticide-spraying hole, elastic packing pipe cap is contained in pencil front end, column top plugs in pencil rear portion, diameter with handle top bolt is consistent with column top plug, there is a groove side, and independent packaging, above-mentioned medicine feeding machine is all carried out to inside and outside wall sterilizing, aseptic packaging, and meet hygienic requirement, when use, be with handle top bolt to be assembled on pencil, human body lubricants is coated with to exhibition on pencil outer wall, pencil is sent into gently to the affected area of vagina, push belt handle top bolt, after ointment is all injected, take out medicine feeding machine and abandon it.
CN201310089160.3A 2013-03-20 2013-03-20 Novel prescription, delivering device and preparation method for metronidazole, clotrimazole and chlorhexidine acetate compound ointment Pending CN104055769A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310089160.3A CN104055769A (en) 2013-03-20 2013-03-20 Novel prescription, delivering device and preparation method for metronidazole, clotrimazole and chlorhexidine acetate compound ointment

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310089160.3A CN104055769A (en) 2013-03-20 2013-03-20 Novel prescription, delivering device and preparation method for metronidazole, clotrimazole and chlorhexidine acetate compound ointment

Publications (1)

Publication Number Publication Date
CN104055769A true CN104055769A (en) 2014-09-24

Family

ID=51543889

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310089160.3A Pending CN104055769A (en) 2013-03-20 2013-03-20 Novel prescription, delivering device and preparation method for metronidazole, clotrimazole and chlorhexidine acetate compound ointment

Country Status (1)

Country Link
CN (1) CN104055769A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109045453A (en) * 2018-10-13 2018-12-21 郭锐 Gynaecology's private parts medicator

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109045453A (en) * 2018-10-13 2018-12-21 郭锐 Gynaecology's private parts medicator

Similar Documents

Publication Publication Date Title
CN205095247U (en) Venereal disease branch of academic or vocational study is with multi -functional skin medicator
CN101829041A (en) Sterilizing and itch-relieving gynaecological lotion
WO2011121604A9 (en) A liquid vaginal spray formulation for treatment of vaginal fungal infection
MX2013014884A (en) Applicator system for applying a viscous liquid to the human skin.
AU2014235693B2 (en) Topical copper ion treatments in the genital-rectal areas of the body
CN1879831A (en) Bacteriostatic externally applied preparation for treating gynecological inflammation and method for preparing same
CN105640916A (en) Povidone iodine effervescent tablets with anti-microbial, skin-care and anti-inflammation functions and production process of povidone iodine effervescent tablets
US20070128254A1 (en) Methods of attaching a dosage form to a medicated tampon assembly
CN104055769A (en) Novel prescription, delivering device and preparation method for metronidazole, clotrimazole and chlorhexidine acetate compound ointment
CN104055767A (en) Novel prescription, delivering device and preparation method for Shuangzuotai compound gel
CN104055768A (en) Prescription, delivering device and preparation method for Shuangzuotai compound ointment
EP3801731B1 (en) Applicators for treating vaginal conditions
CN104548100B (en) A kind of dermopathic composition of external curing
EP2994144B1 (en) Topical preparations comprising hyaluronic acid, verbascoside and glycerophosphoinositol
CN211383400U (en) Gel administration device for women
CN104056272A (en) Prescription, delivering device and preparation method for compound ointment used for treating colpitis
CN105816551A (en) Medicinal film used for treating gynecological diseases and maintaining female external genital organs, and production method thereof
FI3773501T3 (en) Intravaginal formulation
CN1036440C (en) Dithiazole ointment and preparing method
CN101254289A (en) Skin disease traditional Chinese medicine preparation and novel preparation thereof
CN101249062A (en) Fibraurea stem element jelly glue preparations and preparation technique thereof
CN201008700Y (en) Disposal medicine feeder for vagina
CN204767004U (en) Disposable pneumatics ware of dosing
US20210016069A1 (en) Applicators for treating vaginal dryness
CN101816679B (en) Film-forming type iodine disinfectant and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140924